Ibopamine | |
---|---|
Salts [] | |
---|---|
Ibopamine hydrochloride | |
Molecular structure via molpic |
Physical properties [] | |
---|---|
Molecular mass | 307.4 g/mol [1] |
Predicted LogP | 2.9 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C17H25NO4 [1] |
IUPAC name | [4-[2-(methylamino)ethyl]-2-(2-methylpropanoyloxy)phenyl] 2-methylpropanoate [1] |
SMILES | CC(C)C(=O)OC1=C(C=C(C=C1)CCNC)OC(=O)C(C)C [1] |
InChI | InChI=1S/C17H25NO4/c1-11(2)16(19)21-14-7-6-13(8-9-18-5)10-15(14)22-17(20)12(3)4/h6-7,10-12,18H,8-9H2,1-5H3 [1] |
InChIKey | WDKXLLJDNUBYCY-UHFFFAOYSA-N [1] |
Dosing |
---|
Ibopamine
Ibopamine (also known as Ibopaminum, Ibopamina, SB 7505, SB-7505, Propanoic acid, 2-methyl-, 4-(2-(methylamino)ethyl)-1,2-phenylene ester, N-methyldopamine diisobutyrate, (4-(2-(methylamino)ethyl)-2-(2-methylpropanoyloxy)phenyl) 2-methylpropanoate, 5-(2-(methylamino)ethyl)-2-((2-methylpropanoyl)oxy)phenyl 2-methylpropanoate, 5-[2-(methylamino)ethyl]-2-[(2-methylpropanoyl)oxy]phenyl 2-methylpropanoate or C01CA16) is a prodrug substance of the carboxylic acid class.
Chemistry
Salts []
Ibopamine is typically found in the form of its hydrochloride salt.
Pharmacology
Ibopamine acts as a prodrug for:
Active metabolites [] |
---|
Subjective effects []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 68555, Ibopamine. Accessed July 19, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/68555
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Ibopamine. UNII: 8ZCA2I2L11. Global Substance Registration System. Accessed July 19, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/8ZCA2I2L11